A

Autobahn Therapeutics, Inc.

30 employees

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$76M

from 12 investors over 12 rounds

A

Autobahn Therapeutics, Inc. raised $33M on September 8, 2022

Investors: The Invus Group, ARCH Venture Partners, Samsara BioCapital, Biogen Idec, Bristol-Myers Squibb, UK and Section 32

A

Autobahn Therapeutics, Inc. raised $76M on June 11, 2020

Investors: The Invus Group, ARCH Venture Partners, Biogen Idec, Section 32, Bristol-Myers Squibb, UK and Samsara BioCapital

FAQ